Search

everythinglearnresearchcommunity

for

Search:↓

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Bicalutamide may help treat female pattern hair loss.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Bicalutamide improves hair density in women safely.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

The study found that baicalin has different stable shapes in gas and water, with two shapes better for interacting with positive charges in water.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.